Plinabulin is a selective androgen receptor modulator currently under investigation for the treatment of muscle wasting associated with cancer cachexia. By selectively activating androgen receptors within… Read more
Plinabulin is a selective androgen receptor modulator currently under investigation for the treatment of muscle wasting associated with cancer cachexia. By selectively activating androgen receptors within skeletal muscle tissues, this compound aims to mitigate muscle loss in cancer patients while sparing other organ systems. Within analytical laboratories, the Plinabulin category provides researchers with essential tools for rigorous quality control and pharmaceutical research. These offerings, which include the parent compound and stable isotope labelled versions like Plinabulin-d5, serve as critical reference standards for precise quantitative analysis. Chemists and analytical scientists utilize these materials for comprehensive impurity profiling, method validation, and pharmacokinetic studies, ensuring accurate identification and quantification of the drug during development and regulatory testing processes. These high-quality reference standards are vital for maintaining consistency and compliance in sensitive bioanalytical assays.